WGS — GeneDx Holdings Corp.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1818331 ·
Last close
$88.40
Market Cap
$2.64B
52W High
$170.87
52W Low
$32.21
ADV30
622,460
Next earnings
2026-10-27
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 114,440,000 | 78,238,000 | -15,243,000 | -17,740,000 | 481,486,000 | 60,317,000 | 237,265,000 |
| Mar 2026 | 102,254,000 | 68,211,000 | -26,184,000 | -63,316,000 | 506,301,000 | 93,924,000 | 252,177,000 |
| Dec 2025 | 120,989,000 | 84,268,000 | -14,235,000 | -17,666,000 | 523,710,000 | 104,997,000 | 215,528,000 |
| Sep 2025 | 116,743,000 | 84,527,000 | -3,251,000 | -7,635,000 | 493,902,000 | 95,968,000 | 201,644,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-48,712,000
Investing CF
$-38,644,000
Financing CF
$73,556,000
CapEx
$-27,086,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-2.67
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-1,454,551,000
Inventory
$17,820,000
Receivables
$83,610,000
ST Investments
$72,231,000
EBIT TTM
$-96,261,000
Pretax Income TTM
$-106,295,000
Interest Exp TTM
$3,359,000
Analysts
9
Yahoo Snapshot (yfinance, live)
Total Revenue
$454,425,984
EBITDA
$-33,695,000
Free Cash Flow
$-47,501,624
Enterprise Value
$2,577,672,960
Total Cash
$132,548,000
Total Debt
$167,402,000
Shares Out
29,822,541
Trailing EPS
$-3.63
Book Value
$8.19
ROE
-40.8%
ROA
-7.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 427,539,000 | -13,077,000 | -21,021,000 | 523,710,000 | 215,528,000 | 308,182,000 | 33,279,000 |
| Dec 2024 | 305,450,000 | -23,213,000 | -52,286,000 | 419,380,000 | 174,133,000 | 245,247,000 | -28,496,000 |
| Dec 2023 | 202,566,000 | -170,194,000 | -175,767,000 | 418,756,000 | 190,739,000 | 228,017,000 | -180,147,000 |
| Dec 2022 | 234,694,000 | -457,507,000 | -548,980,000 | 490,942,000 | 237,237,000 | 253,705,000 | -319,155,000 |
TTM Snapshot
Revenues TTM
$300,526,000
NetIncome TTM
$-134,708,000
OpCashFlow TTM
$0
Assets (Latest)
$523,710,000
Forward EPS
$1.17
Max Pain — expiry 2026-12-18
max pain strike: $72.50 · spot: $86.79 · call oi: 1,540 · put oi: 729
Expected Move to 2026-12-18:
±$25.70
(29.61%) —
implied range
$61.09 –
$112.49
· ATM straddle on $87.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BKD | Brookdale Senior Living Inc. | $2.65B | $11.11 | — |
| ACHC | Acadia Healthcare Company, Inc. | $2.62B | $28.09 | — |
| AVAH | Aveanna Healthcare Holdings, Inc. | $2.71B | $12.41 | — |
| PRVA | Privia Health Group, Inc. | $2.52B | $19.71 | — |
| MD | Pediatrix Medical Group, Inc. | $2.14B | $26.31 | — |
News headlines (Yahoo Finance, 1h cache)
GeneDx Stock Is Down 30% In Last 1 Year, Can It Climb Again in 2027?
2026-09-24 13:33 · Yahoo
GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
2026-08-24 12:30 · Yahoo
Can GENEDX HOLDINGS (WGS) Run Higher on Rising Earnings Estimates?
2026-08-19 16:20 · Yahoo
GeneDx (WGS) Q2 2026 Earnings Call Transcript
2026-08-11 01:46 · Yahoo
GeneDx Holdings Corp (WGS) (Q2 2026) Earnings Call Highlights: Record Volume and Early ...
2026-08-04 05:07 · Yahoo
GeneDx Q2 Earnings Call Highlights
2026-08-03 23:03 · Yahoo
GeneDx Holdings Corp. (WGS) Slid as Revenue Fell Short of Expectations
2026-07-21 14:04 · Yahoo
GeneDx to Report Second Quarter 2026 Financial Results on Monday, August 3, 2026
2026-07-16 20:05 · Yahoo
GeneDx to Participate in Upcoming Investor Conferences
2026-08-06 20:05 · Yahoo
GeneDx and Beren Therapeutics Launch NPC GenomeComplete to Improve Diagnosis of Niemann-Pick Disease Type C
2026-09-09 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.